| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
KNSA
Kiniksa Pharmaceuticals
|
Oct 28, 2026 | BUY |
Strong Buy
-11.0% avg upside
12 analysts
|
$110.00
19.19% Upside
|
-7.2% | · |
|
PHVS
Pharvaris
|
Oct 15, 2026 | BUY |
Strong Buy
+67.0% avg upside
15 analysts
|
$65.00
93.93% Upside
|
+15.6% | · |
|
BBIO
BridgeBio Pharma
|
Oct 15, 2026 | BUY |
Strong Buy
+26.0% avg upside
36 analysts
|
$102.00
36.02% Upside
|
+16.0% | · |
|
EDIT
Editas Medicine
|
Oct 08, 2026 | BUY |
Buy
+398.5% avg upside
33 analysts
|
$6.00
124.71% Upside
|
+3.2% | · |
|
BEAM
Beam Therapeutics
|
Oct 02, 2026 | BUY |
Strong Buy
+91.2% avg upside
25 analysts
|
$70.00
157.12% Upside
|
+8.2% | · |
|
CRSP
Crispr Therapeutics AG
|
Oct 02, 2026 | HOLD |
Buy
+45.6% avg upside
41 analysts
|
$75.00
45.84% Upside
|
-12.4% | · |
|
SYRE
Spyre Therapeutics
|
Oct 02, 2026 | BUY |
Strong Buy
+0.9% avg upside
25 analysts
|
$115.00
19.05% Upside
|
+3.6% | · |
|
SRPT
Sarepta Therapeutics
|
Oct 02, 2026 | BUY |
Buy
+223.8% avg upside
50 analysts
|
$38.00
104.17% Upside
|
+6.4% | · |
|
CYTK
Cytokinetics
|
Oct 02, 2026 | BUY |
Strong Buy
+43.4% avg upside
36 analysts
|
$105.00
66.76% Upside
|
-15.3% | · |
|
RNA
Atrium Therapeutics, Inc.
|
Oct 02, 2026 | BUY |
Strong Buy
+246.6% avg upside
6 analysts
|
$25.00
202.32% Upside
|
+11.2% | · |
|
ENGN
enGene Holdings
|
Oct 02, 2026 | HOLD |
Buy
+553.6% avg upside
13 analysts
|
$2.00
30.72% Upside
|
-13.4% | · |
|
NAMS
NewAmsterdam Pharma Company
|
Oct 02, 2026 | BUY |
Strong Buy
+136.0% avg upside
19 analysts
|
$55.00
174.17% Upside
|
-18.6% | · |
|
IOVA
Iovance Biotherapeutics
|
Sep 30, 2026 | BUY |
Strong Buy
+83.7% avg upside
26 analysts
|
$18.00
112.18% Upside
|
-41.3% | · |
|
STRO
Sutro Biopharma
|
Sep 29, 2026 | BUY |
Strong Buy
+357.6% avg upside
22 analysts
|
$49.00
438.44% Upside
|
-42.5% | · |
|
ZNTL
Zentalis Pharmaceuticals
|
Sep 29, 2026 | HOLD |
Buy
+585.1% avg upside
20 analysts
|
$5.00
155.02% Upside
|
-35.2% | · |
|
QURE
uniQure
|
Sep 29, 2026 | BUY |
Strong Buy
+121.1% avg upside
30 analysts
|
$75.00
202.06% Upside
|
+391.4% | · |
|
SCTX
Scribe Therapeutics Inc.
|
Aug 31, 2026 | BUY |
Strong Buy
+235.6% avg upside
4 analysts
|
$60.00
289.13% Upside
|
-45.1% | · |
|
IONS
Ionis Pharmaceuticals
|
Aug 14, 2026 | BUY |
Strong Buy
+74.1% avg upside
44 analysts
|
$95.00
118.37% Upside
|
-28.0% | · |
|
MGX
Metagenomi, Inc.
|
Aug 11, 2026 | BUY |
Strong Buy
+1032.0% avg upside
8 analysts
|
$7.00
797.10% Upside
|
-36.4% | · |
|
ONC
BeOne Medicines
|
Aug 06, 2026 | BUY |
Strong Buy
-1.2% avg upside
29 analysts
|
$400.00
8.11% Upside
|
+17.4% | · |
|
SGMOQ
Sangamo Therapeutics
|
Jun 25, 2026 | HOLD |
Buy
+9563.8% avg upside
16 analysts
|
— | +200.0% | · |
|
NTLA
Intellia Therapeutics
|
May 12, 2026 | HOLD |
Buy
+187.2% avg upside
39 analysts
|
$15.00
20.30% Upside
|
-20.7% | · |
|
TSHA
Taysha Gene Therapies
|
May 07, 2026 | BUY |
Strong Buy
+241.9% avg upside
22 analysts
|
$11.00
166.41% Upside
|
-40.0% | · |
|
ARCT
Arcturus Therapeutics
|
Mar 04, 2026 | BUY |
Buy
+175.7% avg upside
36 analysts
|
$20.00
81.41% Upside
|
+45.5% | · |
|
AUTL
Autolus Therapeutics
|
Jan 14, 2026 | BUY |
Strong Buy
+599.0% avg upside
16 analysts
|
$5.00
228.87% Upside
|
-11.3% | · |
|
CLLS
Cellectis SA
|
Jan 13, 2026 | HOLD |
Strong Buy
+1837.3% avg upside
16 analysts
|
$4.00
270.32% Upside
|
-74.4% | · |
|
FATE
Fate Therapeutics
|
Jan 05, 2026 | HOLD |
Buy
+482.8% avg upside
31 analysts
|
$2.50
20.22% Upside
|
+102.0% | · |
|
ADAPY
Adaptimmune Therapeutics
|
May 14, 2025 | HOLD |
Buy
+9923.8% avg upside
10 analysts
|
$1.00
4247.86% Upside
|
-92.7% | · |
|
AFMDQ
Affimed
|
May 14, 2025 | HOLD |
Buy
+1359021112.1% avg upside
16 analysts
|
$0.10
9999900.00% Upside
|
· | · |
|
VYGR
Voyager Therapeutics
|
May 06, 2025 | BUY |
Strong Buy
+730.1% avg upside
23 analysts
|
$10.00
481.46% Upside
|
+28.3% | · |
|
TECX
Tectonic Therapeutic
|
May 16, 2024 | HOLD |
Strong Buy
+176.5% avg upside
24 analysts
|
— | +25.8% | · |
|
TCRT
Alaunos Therapeutics
|
Aug 16, 2023 | HOLD |
Buy
+723.4% avg upside
13 analysts
|
$30.00
1438.54% Upside
|
-90.5% | · |
|
ARGX
Argenx Se
|
Feb 02, 2021 | HOLD |
Strong Buy
-8.2% avg upside
48 analysts
|
$326.00
63.46% Downside
|
-14.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.